Arrowhead Pharmaceuticals, Inc. financial data

Symbol
ARWR on Nasdaq
Location
177 E Colorado Blvd, Suite 700, Pasadena, CA
Fiscal year end
September 30
Latest financial report
10-K - Q3 2025 - Nov 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 512 % -12.6%
Return On Equity -0.37 % +99.8%
Return On Assets -0.12 % +99.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 136M shares +7.7%
Common Stock, Shares, Outstanding 136M shares +9.11%
Entity Public Float 1.4B USD -53.3%
Common Stock, Value, Issued 231K USD +6.45%
Weighted Average Number of Shares Outstanding, Basic 134M shares +11.7%
Weighted Average Number of Shares Outstanding, Diluted 134M shares +11.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 829M USD +23258%
General and Administrative Expense 124M USD +25.5%
Operating Income (Loss) 98.3M USD
Nonoperating Income (Expense) -46.8M USD -311%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 51.5M USD
Income Tax Expense (Benefit) 4.73M USD
Net Income (Loss) Attributable to Parent -1.63M USD +99.7%
Earnings Per Share, Basic 0 USD/shares +99.8%
Earnings Per Share, Diluted 0 USD/shares +99.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 69.4M USD -34.1%
Accounts Receivable, after Allowance for Credit Loss, Current 6.82M USD
Other Assets, Current 13.5M USD +172%
Assets, Current 951M USD +36.7%
Property, Plant and Equipment, Net 383M USD -0.91%
Operating Lease, Right-of-Use Asset 43.9M USD -3.01%
Other Assets, Noncurrent 1.39M USD -69%
Assets 1.39B USD +21.5%
Accounts Payable, Current 17.7M USD +55.2%
Employee-related Liabilities, Current 26.9M USD +22.3%
Accrued Liabilities, Current 90.4M USD +43.5%
Contract with Customer, Liability, Current 2.4M USD
Liabilities, Current 195M USD +89.5%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 104M USD -6.23%
Other Liabilities, Noncurrent 669K USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 6.44M USD +35.6%
Retained Earnings (Accumulated Deficit) -1.63B USD -0.1%
Stockholders' Equity Attributable to Parent 466M USD +151%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 503M USD +163%
Liabilities and Equity 1.39B USD +21.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -146M USD -24.1%
Net Cash Provided by (Used in) Financing Activities 20.6M USD +7628%
Net Cash Provided by (Used in) Investing Activities 76.9M USD +18.6%
Common Stock, Shares Authorized 290M shares 0%
Common Stock, Shares, Issued 136M shares +9.11%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 227M USD +121%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 498M USD +10.8%
Deferred Tax Assets, Gross 563M USD +19%
Operating Lease, Liability 111M USD -5.09%
Payments to Acquire Property, Plant, and Equipment 7.52M USD -89.1%
Lessee, Operating Lease, Liability, to be Paid 174M USD -7.95%
Property, Plant and Equipment, Gross 463M USD +4.2%
Operating Lease, Liability, Current 7.29M USD +14.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.1M USD -4.74%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.9M USD +2.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 62.2M USD -12.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 13.7M USD -8.54%
Deferred Tax Assets, Operating Loss Carryforwards 70.9M USD -31%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 22.2M USD +33.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14M USD +2.69%
Operating Lease, Payments 15.5M USD +40.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.7M USD 0%
Depreciation, Depletion and Amortization 22.2M USD +31.4%
Share-based Payment Arrangement, Expense 54.8M USD -18.3%
Interest Expense 23M USD +43.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%